舒巴坦联合美罗培南治疗泛耐药鲍曼不动杆菌颅内感染的用药分析

The Analysis of Drug use for Sulbactam Combined with Meropenem for Pandrug-Resistant Acinetobacter Baumannii in Intracranial Infection

颅内感染是神经外科术后常见并发症,其中鲍曼不动杆菌在最近几年脑脊液分离菌中分离率最高,并且耐药趋势严重,病死率高。本文主要从1例神经外科术后入住ICU期间的患者,使用舒巴坦联合美罗培南治疗颅内泛耐药鲍曼不动杆菌感染的用药情况进行分析总结,旨在为临床用药提供参考。

Intracranial infection is a kind of common postoperative complications of neurosurgical, the highest checkout rate of acinetobacterbaumannii in cerebral spinal fluid （CSF） culture in recent years. The trend of drug resistance is very serious. And Multidrug-Resistant Acinetobacterbaumannii has higher death rate. The case mainly analyzed and summarized sulbactam combined with meropenem for Pandrug-ResistantAcinetobacter baumannii in intracranial Infection. The purpose of it is to provide reference for clinical medication.